Blog

Anirban Maitra: The Revolution Medicines siblings

Anirban Maitra/X

Jan 15, 2025, 14:22

Anirban Maitra: The Revolution Medicines siblings

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a post on X:

“The Revolution Medicines siblings – Darax, Eli and Zold.

RMC-6236 (RAS ON MULTI) = DaraxONRASib.
RMC-6291 (12C ON) = EliONRASib.
RMC-9805 (12D ON) = ZoldONRASib.

At least that’s how I will remember their names. Via JPM25.”

Dr. Anirban Maitra serves as a Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.

Anirban Maitra cancer Darax DaraxONRASib Eli EliONRASib fight against cancer Global fight against cancer OncoDaily Oncology Pathology Revolution Translational Molecular Pathology UT MD Anderson Cancer Center ZoldONRASib

Senator Edward Markley in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity